BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17146971)

  • 1. The association of increased lung resistance protein expression with acquired etoposide resistance in human H460 lung cancer cell lines.
    Lee E; Lim SJ
    Arch Pharm Res; 2006 Nov; 29(11):1018-23. PubMed ID: 17146971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential overexpression of LRP and MRP but not P-gp 170 in VP16-selected A549 adenocarcinoma cells.
    Trussardi A; Poitevin G; Gorisse MC; Faroux MJ; Bobichon H; Delvincourt C; Jardillier JC
    Int J Oncol; 1998 Sep; 13(3):543-8. PubMed ID: 9683791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A very early induction of major vault protein accompanied by increased drug resistance in U-937 cells.
    Hu Y; Stephen AG; Cao J; Tanzer LR; Slapak CA; Harrison SD; Devanarayan V; Dantzig AH; Starling JJ; Rome LH; Moore RE
    Int J Cancer; 2002 Jan; 97(2):149-56. PubMed ID: 11774257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annexin-I expression modulates drug resistance in tumor cells.
    Wang Y; Serfass L; Roy MO; Wong J; Bonneau AM; Georges E
    Biochem Biophys Res Commun; 2004 Feb; 314(2):565-70. PubMed ID: 14733945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of multidrug resistance associated transporters (MDR1, MRP1, LRP and BCRP) in porcine oocyte.
    Takebayashi Y; Nakayama K; Fujioka T; Kanzaki A; Mutho M; Uchida T; Miyazaki K; Ito M; Fukumoto M
    Int J Mol Med; 2001 Apr; 7(4):397-400. PubMed ID: 11254880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
    Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
    Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) expression in acute promyelocytic leukaemia.
    Michieli M; Damiani D; Ermacora A; Geromin A; Michelutti A; Masolini P; Baccarani M
    Br J Haematol; 2000 Mar; 108(4):703-9. PubMed ID: 10792272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic significance of P-glycoprotein, multidrug resistance-related protein 1 and lung resistance protein in pediatric acute lymphoblastic leukemia: a retrospective study of 295 newly diagnosed patients by the Children's Oncology Group.
    Olson DP; Taylor BJ; La M; Sather H; Reaman GH; Ivy SP
    Leuk Lymphoma; 2005 May; 46(5):681-91. PubMed ID: 16019505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding and inhibition of drug transport proteins by heparin: a potential drug transporter modulator capable of reducing multidrug resistance in human cancer cells.
    Chen Y; Scully M; Petralia G; Kakkar A
    Cancer Biol Ther; 2014 Jan; 15(1):135-45. PubMed ID: 24253450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the lung resistance-related protein (LRP) in the drug sensitivity of cultured tumor cells.
    Meschini S; Marra M; Calcabrini A; Monti E; Gariboldi M; Dolfini E; Arancia G
    Toxicol In Vitro; 2002 Aug; 16(4):389-98. PubMed ID: 12110277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance.
    Li G; Chen X; Wang Q; Xu Z; Zhang W; Ye L
    J Huazhong Univ Sci Technolog Med Sci; 2007 Apr; 27(2):173-5. PubMed ID: 17497289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FLT3-ITD and MLL-PTD influence the expression of MDR-1, MRP-1, and BCRP mRNA but not LRP mRNA assessed with RQ-PCR method in adult acute myeloid leukemia.
    Nasilowska-Adamska B; Solarska I; Paluszewska M; Malinowska I; Jedrzejczak WW; Warzocha K
    Ann Hematol; 2014 Apr; 93(4):577-93. PubMed ID: 24030729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential gene expression of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and lung resistance protein: functional activity of P-gp and MRP present in the doxorubicin-resistant human K562 cell lines.
    Grandjean F; Brémaud L; Verdier M; Robert J; Ratinaud MH
    Anticancer Drugs; 2001 Mar; 12(3):247-58. PubMed ID: 11290872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical expression of multidrug resistance proteins in mature T/NK-cell lymphomas.
    Saglam A; Hayran M; Uner AH
    APMIS; 2008 Sep; 116(9):791-800. PubMed ID: 19024599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDR 1 activation is the predominant resistance mechanism selected by vinblastine in MES-SA cells.
    Chen GK; Durán GE; Mangili A; Beketic-Oreskovic L; Sikic BI
    Br J Cancer; 2000 Oct; 83(7):892-8. PubMed ID: 10970691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of multidrug resistance-related transporters in human breast carcinoma.
    Kanzaki A; Toi M; Nakayama K; Bando H; Mutoh M; Uchida T; Fukumoto M; Takebayashi Y
    Jpn J Cancer Res; 2001 Apr; 92(4):452-8. PubMed ID: 11346468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of P-gp, MRP, LRP, GST-π and TopoIIα and intrinsic resistance in human lung cancer cell lines.
    Wang J; Zhang J; Zhang L; Zhao L; Fan S; Yang Z; Gao F; Kong Y; Xiao GG; Wang Q
    Oncol Rep; 2011 Nov; 26(5):1081-9. PubMed ID: 21805041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts.
    Kolfschoten GM; Hulscher TM; Pinedo HM; Boven E
    Br J Cancer; 2000 Oct; 83(7):921-7. PubMed ID: 10970695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.